Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06295549
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2024-02-18
Brief Title:
Targeting CD19CD20 Dual-targeted Cell in Patients With RelapsedRefractory B-cell Non-Hodgkin Lymphoma
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
The First Affiliated Hospital with Nanjing Medical University
Organization Data
Organization:
The First Affiliated Hospital with Nanjing Medical University
Class:
OTHER
Study ID:
LB2304-0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Nanjing Legend Biotech Co | INDUSTRY |